What is leukemia in plasma?
Leukemia
Plasma cell (PCL) is a rare and aggressive form of cancer, which can develop in itself or from an existing case of multiple myeloma. In PCL, plasma cells are quickly reproduced in the blood. The long -term survival rate under this condition is poor. The disease is diagnosed with bone marrow biopsy and blood tests.
Men and women are equally likely that leukemia in plasma cells that develop most often in individuals aged 50 to 60 years. Symptoms of leukemia of plasma cells include frequent infections, anemia, fever or kidney failure. The disease can also lead to bone and fracture loss.
PCL and related diseases, multiple myloma, are cancer of plasma cells. Plasma cells are a type of white blood cells that produce antibodies. When these abnormal plasma cells are reproduced and clustered in bones, they create lesions that can lead to fractures.
bone lesions disrupt the ability of the body to produce normal BuThe sides that fight the infection to wear oxygen with the body. When abnormal cells attack bones, this can lead to elevated calcium levels, which can cause kidney tension as well as confusion and weakness. Increased calcium levels are the result of calcium from the patient bone entering the bloodstream when the bones dissolve.
Fatigue and frequent infections are two more common symptoms of leukemia in plasma cells. Fatigue evolves because abnormal cells replace red blood cells in the body. The task of red blood cells is to carry oxygen through the body and the low number of red blood cells calculates the energy of the body.
infections such as shingles, skin infections, pneumonia and bladder and kidney infections are common in individuals with PCL. These infections develop because abnormal cells prevent the body from producing antibodies. With the threat to the immune system, these infections become uncontrollable.
Symptoms of multiple leukemiaMyloma and plasma cells are similar. PCL is more aggressive with a worse level of survival. Individuals with PCL have greater frequency of organs, a larger number of tumors, a high blood calcium level and a lower number of plates.
treatment of leukemia of plasma cells involves aggressive chemotherapy and stem cell transplantation. The side effects of this treatment include weakness, anemia and nausea. Aggressive regimens of chemotherapy using a combination of drugs increase survival levels from two to six months to 18 to 20 months. Stem cell transplantation can provide a survival window without two to three years.